The Medical Letter on Drugs and Therapeutics
Drugs for Asthma
The full article is available to subscribers Subscriber Login   
TOPICS IN THIS ISSUEInhaled SABAsInhaled SAMAInhaled CorticosteroidsInhaled LABAsInhaled LAMAsLeukotriene ModifiersTheophyllineOral CorticosteroidsFailure of Standard Treatment Phenotype-Targeted TherapiesImmunotherapyOmalizumabAnti-Interleukin-5 (Il-5) AntibodiesBronchial Thermoplasty ... more       Show References Hide References
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Drugs for Asthma
Article code: 1528a
 Electronic, downloadable article - $25